Vestal Point Capital, LP - Sep 30, 2025 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)

Filing Manager: Vestal Point Capital, LP
Reporting Manager: Vestal Point Capital, LP
Security: Astria Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: ATXS
Shares outstanding: 56.3M shares
Disclosed Ownership: 4.96M shares
Ownership: 8.8%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:02 PM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vestal Point Capital, LP	8.8%	4.96M	0	4.96M	/s/ Ryan Wilder	By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder	8.8%	4.96M	0	4.96M	/s/ Ryan Wilder	Ryan Wilder, Individually